Human capital gaps in vaccine development: an issue for global vaccine development and global health
| Autor: | Emilio Emini, William C. Gruber, John J. Donnelly, Michael L. Watson, Joanna Dailey, Dina B. Tresnan, Andrea Cawein, Stanley A. Plotkin, Thomas G. Evans |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Economic growth business.industry General Neuroscience Public health media_common.quotation_subject Human capital General Biochemistry Genetics and Molecular Biology Biotechnology Scarcity 03 medical and health sciences 0302 clinical medicine History and Philosophy of Science 030225 pediatrics medicine Global health 030212 general & internal medicine Business Capital Financing media_common |
| Zdroj: | Annals of the New York Academy of Sciences. 1395:3-11 |
| ISSN: | 0077-8923 |
| DOI: | 10.1111/nyas.13316 |
| Popis: | Despite the success of vaccines in reducing the morbidity and mortality associated with infectious diseases, many infectious diseases, both newly emerging and well known, lack vaccines. The global capability for beginning-to-end vaccine development has become limited, primarily owing to a scarcity of human capital necessary to guide the development of novel vaccines from the laboratory to the marketplace. Here, we identify and discuss the gaps in human capital necessary for robust vaccine development and make recommendations to begin to address these deficiencies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|